In the title carboxyl-ate-bridged polymer, [Sn(C(7)H(7))(3)(C(7)H(5)O(3))](n), the Sn(IV) atom exists in a distorted trans-C(3)SnO(2) trigonal-bipyramidal geometry. The polymer propagates as a chain along the a axis. There are two independent formula units in the asymmetric unit; the furyl ring of one of the anions is disordered over two positions in a 0.630 (8):0.370 (8) ratio. The crystal studied was a non-merohedral twin with a minor twin domain of 37.3 (1)%.
The six-coordinate Sn(IV) atom in the title compound, [Sn(C(7)H(6)F)(2)Cl(2)(C(10)H(8)N(2))], shows a trans-C(2)SnN(2)Cl(2) octa-hedral coordination [C-Sn-C = 174.81 (10) and 176.71 (9)° in the two independent mol-ecules in the asymmetric unit]; the Cl atoms are cis to each other as are the N atoms of the chelating N-heterocycle.
The formyl-meth-oxy-nitro-phenoxide ions in the polymeric title compound, [Sn(C(7)H(7))(3)(C(8)H(6)NO(5))](n), link adjacent triorganotin(IV) cations into linear chains lying close to (101) [Sn-O = 2.1227 (12) Å and Sn← O = 2.4936 (13) Å]. The Sn(IV) atom is displaced out of the C(3)Sn girdle of the trans-C(3)SnO(2) trigonal-bipyramidal polyhedron in the direction of the covalently-bonded O atom [Sn-O-C = 137.63 (11)°] by 0.247 (1) Å; the geometry is distorted towards an octa-hedron by a remote O atom of the meth-oxy subsituent [Sn⋯O = 3.019 (1) Å].
In the title mol-ecule, [Sn(C(7)H(6)Cl)(2)(C(6)H(4)NO(2))(2)(H(2)O)], the O atoms of the two chelating nicotinate groups and the O atom of the coordinated water mol-ecule comprise the penta-gonal plane of the trans-C(2)SnO(5) penta-gonal-bipyramid [C-Sn-C = 178.62 (11) °] surrounding the Sn(IV) atom. In the crystal, adjacent mol-ecules are linked by O-H⋯N hydrogen bonds, generating a chain running along the body diagonal of the triclinic unit cell.
The dinuclear title complex, [Sn(2)(C(7)H(6)Cl)(4)(C(9)H(16)NO(2)S(2))(4)], lies on a center of inversion. The Sn(IV) atoms are chelated by one of the two carboxyl-ate ions; the other carboxyl-ate ion bridges two metal atoms. The geometry of the six-coordinate Sn(IV) atom is a distorted trans-C(2)SnO(4) octa-hedron [C-Sn-C = 155.32 (8)°].
The Sn(IV) atom in the title compound, [Sn(C(7)H(6)Cl)(3)(C(10)H(9)O(2))], exists in a tetra-hedral geometry [Σ C-Sn-C = 341.5 (4)°]. If the doubly bonded carbonyl O atom is taken into account for the coordination sphere of Sn [Sn⋯O = 2.808 (2) Å], the coordination geometry can be described as a cis-penta-gonal bipyramid.
The Sn(IV) atom in the three independent mol-ecules of the title compound, [Sn(C(7)H(6)Cl)(2)(C(9)H(6)NO)Cl], is N,O-chelated by the quinolin-8-olate anion and exists in a cis-C(2)SnNOCl trigonal-bipyramidal geometry; the O atom of the anion and the two benzyl C atoms lie in the equatorial plane.
The six-coordinate Sn(IV) atom in the title compound, [SnCl(4)(C(14)H(14)OS)(2)], exists in a cis-SnCl(4)O(2) octa-hedral geometry. Of the four Cl atoms, two are close to adjacent S atoms [Cl⋯S = 3.320 (1) and 3.376 (1) Å]; the Sn-Cl bonds involving these two Cl atoms are longer than the other two Sn-Cl bonds.
The six-coordinate Sn(IV) atom in the title compound, [Sn(C(8)H(9))Cl(3)(C(3)H(4)N(2))(2)], shows an octa-hedral coordination. The N atoms of the N-heterocycle are cis to each other. The Sn-N bond that is trans to the Sn-C bond is shorter than the Sn-N bond trans to the Sn-Cl bond. Weak N-H⋯Cl hydrogen bonds link adjacent mol-ecules, generating a double chain running along the c axis.
In the title salt, [C(6)H(5)N(CH(3))(3)][Sn(2)Br(5)(C(7)H(6)Br)(4)], the Sn(IV) atoms of the dinuclear anion are bridged by a Br atom; the Sn-Br(bridge) bond lengths are 2.9818 (5) and 3.0470 (5) Å. Both Sn atoms show a distorted cis-trigonal-bipyramidal coordination geometry that is distorted towards a square pyramid. In the crystal, weak C-H⋯π inter-actions occur between anions and cations.
The crystal structure of the title salt, [Sn(C(7)H(7))(3)(C(18)H(15)AsO)(2)][B(C(6)H(5))(4)], consists of discrete cations and anions; the tin atom of the cation is five-coordinated in a distorted trans-C(3)SnO(2) trigonal-bipyramidal geometry [summation of C-Sn-C angles 360.0 (3)° and O-Sn-O angle 173.1 (1)°]. The structure contains voids of 113 (19) Å(3), but no solvent mol-ecule could reasonably be located there.
The Sn atom in the title compound, [Sn(C(7)H(6)Cl)(3)(C(8)H(14)NO(2)S(2))], is coordinated by three chlorobenzyl ligands and one carboxylate O atom of the substituted acetate ligand in a distorted tetra-hedral environment. Three of the C atoms of the n-butyl group are disordered over two sites with equal occupancies.
The tin(IV) atom in the title compound, [Sn(C(8)H(9))(2)Cl(2)(C(12)H(8)N(2))], is chelated by the N-heterocycle and bonded to two C atoms and two chloride ions in an SnC(2)Cl(2)N(2) octa-hedral coordination environment with the C atoms trans to each other. The dihedral angles between the heterocycle ring system and the benzene rings of the 4-methyl-benzyl groups are 21.20 (12) and 28.71 (11)°.
The tin atom in the title compound, [Sn(C(7)H(6)Cl)(3)(C(11)H(11)O(4))], exists in a distorted tetra-hedral coordination environment. The carboxyl-ate anion is equally disordered over two positions.
In the title compound, [Sn(C(7)H(6)F)(3)(C(9)H(16)NO(2)S(2))](n), the Sn atom is coordinated in a slightly distorted, trans-C(3)SnO(2) trigonal-bipyramidal environment. Symmetry-related Sn atoms are bridged by diisopropyl-dithio-carbamoylacetato ligands, forming a one-dimensional polymer along [001].
The Sn atom in the title polymeric compound, [Sn(C(7)H(7))(3)(C(8)H(12)NO(2)S(2))](n), exists in a trans-C(3)O(2) trigonal-bipyramidal coordination environment in the two independent formula units. The carboxyl-ate moiety functions in a bridging mode, linking adjacent triorganotin cations into a linear chain running along the shortest axis of the triclinic unit cell; the repeat distance of the polymer is half the a-axial length. In one formula unit, the Sn atom is displaced out of the equatorial plane in the direction of the Sn-O(covalent) bond by 0.093 (4) Å and in the second mol-ecule, the Sn atom is displaced by 0.105 (4) Å in the same direction.
Tris(2-chloro-benz-yl)tin hydroxide condenses with 3-mercapto-1,2,4-triazole to form the 1:1 cocrystal of the title compound, [Sn(C(7)H(6)Cl)(3)(C(2)H(2)N(3)S)]. The asymmetric unit contains two mol-ecules which differ only in the position of the nitro-gen-bound H atom of the triazole ring; one mol-ecule is linked to the other mol-ecule by an N-H⋯N hydrogen bond. In the second mol-ecule, two of the chloro-benzyl units are disordered over two positions in a 0.73 (1):0.27 (1) ratio. The Sn atom in both mol-ecules shows a distorted tetra-hedral SnSC(3) coordination.
The Sn(IV) atom in the title compound, [Sn(C(7)H(6)Cl)(2)Cl(2)(C(12)H(12)N(2))], is coordinated by the bidentate N-heterocycle mol-ecule, two chloro-benzyl anions and two Cl(-) anions in a distorted trans-C(2)SnCl(2)N(2) octa-hedral geometry [C-Sn-C = 178.4 (1)°]. In the mol-ecular structure, the two benzene rings are oriented at a dihedral angle of 39.62 (17)°.
Peritonitis is well recognized as the Achilles tendon of peritoneal dialysis (PD). Reoccurrence of peritonitis due to the same organism, defined as either repeat or relapsing peritonitis under the 2005 guidelines by the International Society for Peritoneal Dialysis, often results in PD technique failure. Rothia dentocariosa, a low-virulent human oropharynx commensal, is a rarely reported pathogen in human infection, particularly infective endocarditis. R. dentocariosa PD-related peritonitis is exceedingly uncommon yet potentially results in repeat or relapsing peritonitis which requires catheter removal. We report a case of R. dentocariosa repeat and relapsing peritonitis in a PD patient who was treated successfully with antimicrobial therapy.
Pneumocystis jirovecii (formerly Pneumocystis carinii) pneumonia (PCP) is a rare but serious infection that usually occurs within a year after solid organ transplantation. PCP may occur after 1 year post transplantation, but the rate is reported to be very low. Studies have shown an association between cytomegalovirus (CMV) infection in solid organ transplant patients and an increased risk of opportunistic infection. This increased risk is thought to be a result of the immunomodulatory effects of the CMV infection. We present a case of PCP infection occurring 13 years after a renal transplantation. This occurred following a recurrent CMV infection while the patient was on low-dose immunosuppressants.